DEC 24, 2015 12:51 PM PST

New Drug Combats Mold Disease

WRITTEN BY: Kerry Evans
People suffering from leukemia or lymphoma are particularly vulnerable to mold diseases such as aspergillosis and mucormycosis.  The drug voriconazole is often used to treat these infections, but causes serious side effects such as kidney and liver damage.  Recently, researchers at the University of California, Davis, confirmed that the drug isavuconazole is just as effective as voriconazole, while causing far fewer side effects.
 
Aspergillus causes serious infections in the immunocompromised.

According to study author George Thompson, “molds are ubiquitous in the environment, but they are generally no consequence for people with intact immune systems … however, for leukemia and lymphoma patients, and others with compromised immune systems, some molds can be 90% fatal”.  

Aspergillosis is caused by mold in the genus Aspergillus.  The mold spores enter the lungs where they can grow into a “fungus ball”.  In the immunocompromised, the spores make their way into the bloodstream where the mold can infect the heart and kidneys.  Mucormycosis, on the other hand, is a disease caused by mold from the order Mucorales where hyphae grow in and around blood vessels. These molds typically infect the sinuses and brain, but can also spread to the gastrointestinal tract.  

In the UC Davis study, 35% of infections responded to isavuconazole, and 36.4% responded to voriconazole.  However, only 42.4% of patients taking isavuconazole reported side effects, compared to 59.8% taking voriconazole.  

Since isavuconazole can treat mold disease with fewer side effects, cancer patients aren’t forced to choose between treating the mold or treating the cancer.  According to Thompson, “when these patients get a bad infection, they still need more chemotherapy … it’s one thing to cure the infection but they end up dying of leukemia.  Now that there’s a drug with fewer side effects, patients can hopefully continue their chemotherapy with fewer interruptions”.

Sources: Futurity, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
AUG 21, 2020
Microbiology
Vaccine Aimed at Fungi May Also Protect Against MRSA
AUG 21, 2020
Vaccine Aimed at Fungi May Also Protect Against MRSA
Staphylococcus aureus is a common bacterium. If it stays on the skin it's harmless, but if it gets into the bloodstream, ...
SEP 10, 2020
Space & Astronomy
Could There Be Life on Venus?
SEP 10, 2020
Could There Be Life on Venus?
Venus is the hottest planet in our solar system, reaching 465 degrees Celcius- a temperature hot enough to melt lead. Wh ...
SEP 21, 2020
Microbiology
A Fast, Cheap Way to See if Two Antibiotics Work Together
SEP 21, 2020
A Fast, Cheap Way to See if Two Antibiotics Work Together
When a person has a bacterial infection, doctors can prescribe antibiotics. Some antibiotics combos can work better than ...
SEP 30, 2020
Microbiology
Bringing Attention to a Neglected Disease
SEP 30, 2020
Bringing Attention to a Neglected Disease
Schistosomiasis doesn't get much research attention, but it affects around 240 million people around the world, killing ...
NOV 08, 2020
Genetics & Genomics
Drug-Resistant Microbes Persist in Hospitals After Deep Cleaning
NOV 08, 2020
Drug-Resistant Microbes Persist in Hospitals After Deep Cleaning
Researchers have found that drug-resistant bacteria can hang around even after deep cleaning. They used genome sequencin ...
NOV 18, 2020
Microbiology
Bolivian Health Care Workers Sickened in Outbreak of Chapare Virus
NOV 18, 2020
Bolivian Health Care Workers Sickened in Outbreak of Chapare Virus
Five people in Bolivia are known to have been infected with the Chapare virus, which causes hemorrhagic fever. Some infe ...
Loading Comments...